We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ANR market cap is 8.39M. The company's latest EPS is AUD -0.0086 and P/E is -5.81.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 790k | 1.11M | 487k | 1.25M | 644k |
| Operating Income | -3.42M | -1.97M | -2.54M | -2.04M | -1.46M |
| Net Income | -3.37M | -2M | -2.53M | -2.02M | -1.45M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3.34M | 4.33M | 1.77M | 1.42M | 1.67M |
| Total Liabilities | 487k | 497k | 404k | 494k | 306k |
| Total Equity | 2.86M | 3.83M | 1.36M | 925k | 1.37M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.73M | -2.1M | -2.23M | -2.26M | -1.25M |
| Investing | 4.05M | -4k | -56k | -2k | 50k |
| Financing | N/A | 2.85M | -24k | 1.49M | 1.83M |
| Market Cap | 8.39M |
| Price to Earnings Ratio | -5.81 |
| Price to Sales Ratio | 13.16 |
| Price to Cash Ratio | 8.62 |
| Price to Book Ratio | 6.15 |
| Dividend Yield | - |
| Shares Outstanding | 167.89M |
| Average Volume (1 week) | 53.47k |
| Average Volume (1 Month) | 80.89k |
| 52 Week Change | 117.39% |
| 52 Week High | 0.073 |
| 52 Week Low | 0.021 |
| Spread (Intraday) | 0.01 (14.81%) |
| Company Name | Antara Lifesciences Ltd |
| Address |
level 8, 81 flinders street adelaide, south australia 5000 |
| Website | https://anataralifesciences.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
